
This clinical consensus statement reviews the use of inotropic support in patients with advanced heart failure. The current guidelines only support using inotropes in acute decompensated heart failure with organ malperfusion or shock evidence. However, inotropic support may be reasonable in other patients with advanced heart failure without acute severe decompensation. Traditional and novel drugs with inotropic effects are discussed, and guideline‐directed therapy during inotropic support is reviewed. Finally, home inotropic therapy is described, and palliative care and end‐of‐life aspects are evaluated concerning ongoing inotropic support (including guidance for maintenance and weaning of chronic inotropic therapy support).
Like
Save
Share